Boothbay Fund Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
2025
Q3
$1.27M Sell
2025
Q2
$3.13M Sell
2025
Q1
$4.69M Buy
2024
Q4
$7.04M Buy
2024
Q3
$5.59M Sell
2024
Q2
$6.76M Sell
2024
Q1
$7.61M Buy
2023
Q4
$5.16M Sell
2023
Q3
$4.97M Buy
2023
Q2
$1.74M Buy
2020
Q3
Sell
2020
Q2
$208K Buy